Chimeric antigen receptor T-cell therapies for lymphoma
Chimeric antigen receptor T-cell therapies for lymphoma
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
New treatments are needed for patients with chemotherapy-refractory or multiply-relapsed lymphoma
Chimeric antigen receptor (CAR) T cells targeting CD19 have demonstrated efficacy in multiple subtypes of B-cell lymphoma, with activity seen in patients with chemotherapy-refractory lymphoma; durable remissions are possible
Multice...
Alternative Titles
Full title
Chimeric antigen receptor T-cell therapies for lymphoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1978778867
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1978778867
Other Identifiers
ISSN
1759-4774
E-ISSN
1759-4782
DOI
10.1038/nrclinonc.2017.128
